John C. Martin

2014 - Gilead Sciences

In 2014, John C. Martin earned a total compensation of $19M as Chairman and Chief Executive Officer at Gilead Sciences, a 23% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,717,365
Option Awards$5,241,907
Salary$1,605,017
Stock Awards$8,386,205
Other$7,500
Total$18,957,994

Martin received $8.4M in stock awards, accounting for 44% of the total pay in 2014.

Martin also received $3.7M in non-equity incentive plan, $5.2M in option awards, $1.6M in salary and $7.5K in other compensation.

Rankings

In 2014, John C. Martin's compensation ranked 138th out of 13,032 executives tracked by ExecPay. In other words, Martin earned more than 98.9% of executives.

ClassificationRankingPercentile
All
138
out of 13,032
99th
Division
Manufacturing
52
out of 4,966
99th
Major group
Chemicals And Allied Products
21
out of 1,686
99th
Industry group
Drugs
18
out of 1,365
99th
Industry
Biological Products, Except Diagnostic Substances
1
out of 236
100th
Source: SEC filing on March 28, 2016.

Martin's colleagues

We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2014.

2014

John Milligan

Gilead Sciences

Chief Operating Officer

2014

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2014

Robin Washington

Gilead Sciences

Chief Financial Officer

2014

Gregg Alton

Gilead Sciences

Executive Vice President, Corporate and Medical Affairs

You may also like